| Item | NexLife | Hims & Hers |
|---|---|---|
| What you get | Compounded semaglutide and tirzepatide (not FDA-approved) | Compounded and brand GLP-1s (May 2026 profile) |
| Program or membership fee | None (“No memberships or contracts”) | Not re-read |
| Medication included in that price | Yes: medication, medical guidance from NexLife Medical Group, nutrition plan, coaching call, 24/7 support, shipping | Not re-read |
| Pharmacies named | Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux’s New Drug Store (Lake Charles, LA): 503A | Not re-read |
| 12-month arithmetic | Tirzepatide: $115 × 12 = $1,380. Semaglutide: $95 × 12 = $1,140 (12-month plans). | Not computable without a current first-party read. |
| Price read status | Re-read November 6, 2026 (nexlife.us) | Not re-read: hims.com blocked automated reads on October 15, 2026 |
| Score | 94/100 (v4.1 methodology) | 76/100 (May 2026 review (v3.0 rubric); v4.1 re-score pending) |
Who each program fits
Hims & Hers may fit if you already use its platform for other care and can confirm current prices in its app.
NexLife may fit if you want a compounded GLP-1 at a fixed monthly price that does not rise with the dose, with the pharmacy named before you pay. NexLife is not the lowest-priced program we track: Mondae ($126 tirzepatide, $87 semaglutide) lists lower month-to-month prices, and Eden Health ($99) a lower semaglutide price.
Brand medications such as Wegovy and Zepbound are FDA-approved; compounded semaglutide and tirzepatide are not FDA-approved and are not the same products.
What this comparison cannot tell you
We compared published prices and terms, not clinical quality. We did not enroll with either program, so intake-only fees, the pharmacy on a given shipment and dose-specific prices shown after checkout were not visible. Confirm each figure on the program’s own page before paying.